The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation
Abstract
Neutrophil-independent macrophage responses are a prominent part of delayed-type immune and healing processes and depend on T cell-secreted cytokines. An important mediator in this setting is the phosphoprotein osteopontin, whose secretion by activated T cells confers resistance to infection by several intracellular pathogens through recruitment and activation of macrophages. Here, we analyze the structural basis of this activity following cleavage of the phosphoprotein by thrombin into two fragments. An interaction between the C-terminal domain of osteopontin and the receptor CD44 induces macrophage chemotaxis, and engagement of β3-integrin receptors by a nonoverlapping N-terminal osteopontin domain induces cell spreading and subsequent activation. Serine phosphorylation of the osteopontin molecule on specific sites is required for functional interaction with integrin but not CD44 receptors. Thus, in addition to regulation of intracellular enzymes and substrates, phosphorylation also regulates the biological activity of secreted cytokines. These data, taken as a whole, indicate that the activities of distinct osteopontin domains are required to coordinate macrophage migration and activation and may bear on incompletely understood mechanisms of delayed-type hypersensitivity, wound healing, and granulomatous disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Engineering cell shape and function
Singhvi, R., Kumar, A., Lopez, G. P., Stephanopoulos, G. N., Wang, D. I. C., Whitesides, G. M., & Ingber, D. E. (1994) · Science · doi:10.1126/science.8171320 · Cited by 1,453
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J., & Cantor, H. (2000) · Science · doi:10.1126/science.287.5454.860 · Cited by 1,125
Self-citationOsteopontin: a protein with diverse functions
Denhardt, D. T., & Guo, X. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.15.8262332 · Cited by 1,078
Oldberg, A., Franzén, A., & Heinegård, D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.8819 · Cited by 1,078
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)
Weber, G. F., Ashkar, S., Glimcher, M. J., & Cantor, H. (1996) · Science · doi:10.1126/science.271.5248.509 · Cited by 949
Self-citationAltered wound healing in mice lacking a functional osteopontin gene (spp1).
Liaw, L., Birk, D. E., Ballas, C. B., Whitsitt, J. S., Davidson, J. M., & Hogan, B. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2131 · Cited by 663
Senger, D. R., Ledbetter, S. R., Claffey, K. P., Papadopoulos-Sergiou, A., Peruzzi, C. A., & Detmar, M. J. (1996) · Europe PMC (PubMed Central) · Cited by 544
Liaw, L., Skinner, M. P., Raines, E. W., Ross, R., Cheresh, D. A., Schwartz, S. M., & Giachelli, C. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117718 · Cited by 512
Identification of an Inhibitor of Neovascularization from Cartilage
Moses, M. A., Sudhalter, J., & Langer, R. (1990) · Science · doi:10.1126/science.1694043 · Cited by 477
Participation in Normal Immune Responses of a Metastasis-Inducing Splice Variant of CD44
Arch, R., Wirth, K., Hofmann, M., Ponta, H., Matzku, S., Herrlich, P., & Zöller, M. (1992) · Science · doi:10.1126/science.1496383 · Cited by 403
Liaw, L., Almeida, M., Hart, C. E., Schwartz, S. M., & Giachelli, C. M. (1994) · Circulation Research · doi:10.1161/01.res.74.2.214 · Cited by 393
Giachelli, C. M., Lombardi, D. M., Johnson, R. J., Murry, C. E., & de Almeida, M. A. G. (1998) · Europe PMC (PubMed Central) · Cited by 370
Patarca, R., Freeman, G. J., Singh, R. P., Wei, F. Y., Durfee, T., Blattner, F., Regnier, D. C., Kozak, C. A., Mock, B. A., & Morse, H. C. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.1.145 · Cited by 322
Katagiri, Y. U., Sleeman, J. P., Fujii, H., Herrlich, P., Hotta, H., Tanaka, K., Chikuma, S., Yagita∥, H., Okumura, K., Murakami, M., et al. (1999) · PubMed · Cited by 312
Ek-Rylander, B., Flores, M., Wendel, M., Heinegård, D., & Andersson, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36541-9 · Cited by 312
Unemori, E. N., & Werb, Z. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.3.1021 · Cited by 251
Identification of a bone sialoprotein receptor in osteosarcoma cells.
Oldberg, A., Franzén, A., Heinegård, D., Pierschbacher, M., & Ruoslahti, E. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77652-2 · Cited by 247
Singh, R. P., Patarca, R., Schwartz, J., Singh, P., & Cantor, H. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.6.1931 · Cited by 226
Self-citationOsteopontin: An Interfacial Extracellular Matrix Protein in Mineralized Tissues
Mckee, M. D., & Nanci, A. (1996) · Connective Tissue Research · doi:10.3109/03008209609029192 · Cited by 202
A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis
Nau, G. J., Guilfoile, P., Chupp, G. L., Berman, J. S., Kim, S. J., Kornfeld, H., & Young, R. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6414 · Cited by 190
Osteopontin Expression in Cardiovascular Diseasesa
GIACHELLI, C. M., LIAW, L., MURRY, C. E., SCHWARTZ, S. M., & ALMEIDA, M. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44624.x · Cited by 181
Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis
Stickeler, E., Kittrell, F., Medina, D., & Berget, S. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202671 · Cited by 175
Delayed Expression of Osteopontin after Focal Stroke in the Rat
Wang, X., Louden, C., Yue, T.-L., Ellison, J. A., Barone, F. C., Solleveld, H. A., & Feuerstein, G. Z. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02075.1998 · Cited by 171
Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin
Senger, D. R., & Perruzzi, C. A. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(96)00067-5 · Cited by 156
Osteopontin-Stimulated Vascular Smooth Muscle Cell Migration Is Mediated by β3 Integrin
Yue, T.-L., McKenna, P., Ohlstein, E. H., et al. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1282 · Cited by 129
Singer, I. I., Kawka, D. W., Bayne, E. K., Donatelli, S., Weidner, J. R., Williams, H. R., Ayala, J. M., Mumford, R. A., Lark, M. W., & Glant, T. T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117907 · Cited by 124
Xuan, J., Hota, C., Shigeyama, Y., D'Errico, J. A., Somerman, M. J., & Chambers, A. F. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240570413 · Cited by 106
Structural Requirements for α9β1-Mediated Adhesion and Migration to Thrombin-Cleaved Osteopontin
Smith, L. L., & Giachelli, C. M. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4108 · Cited by 105
Kubota, T., Zhang, Q., Wrana, J. L., Ber, R., Aubin, J. E., Butler, W. T., & Sodek, J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90837-1 · Cited by 101
A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat.
Yu, X., Nikolic‐Paterson, D. J., Mu, W., Giachelli, C. M., Atkins, R. C., Johnson, R., & Lan, H. Y. (1998) · PubMed · Cited by 87
Recombinant GST‐human osteopontin fusion protein is functional in RGD‐dependent cell adhesion
Xuan, J., Hota, C., & Chambers, A. F. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240540213 · Cited by 80
Zhu, X., Luo, C., Ferrier, J., & Sodek, J. (1997) · Biochemical Journal · doi:10.1042/bj3230637 · Cited by 43
Costimulation by Extracellular Matrix Proteins Determines the Response to TCR Ligation
Adler, B., Ashkar, S., Cantor, H., & Weber, G. F. (2001) · Cellular Immunology · doi:10.1006/cimm.2001.1800 · Cited by 31
Self-citationSalih, E., Ashkar, S., Gerstenfeld, L. C., & Glimcher, M. J. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111013 · Cited by 31
Self-citationOsteopontin at the Tumor/Host Interface
Senger, D. R., Brown, L. F., Perruzzi, C. A., Papadopoulos-Sergiou, A., & Water, L. V. D. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44622.x · Cited by 25
Effect of osteoblast supernatants on cancer cell migration and invasion
Giunciuglio, D., Cai, T., Filanti, C., Manduca, P., & Albini, A. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03955-v · Cited by 19
Cited by
Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease
Scatena, M., Liaw, L., & Giachelli, C. M. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.144824 · Cited by 644
The role of osteopontin in inflammatory processes
Lund, S. A., Giachelli, C. M., & Scatena, M. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0068-0 · Cited by 516
CD44 in Cancer Progression: Adhesion, Migration and Growth Regulation
Marhaba, R., & Zöller, M. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032354.94213.69 · Cited by 438
Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes
Kahles, F., Findeisen, H. M., & Bruemmer, D. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.03.004 · Cited by 408
Nomiyama, T., Perez-Tilve, D., Ogawa, D., Gizard, F., Zhao, Y., Heywood, E. B., Jones, K. L., Kawamori, R., Cassis, L. A., Tschöp, M. H., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31986 · Cited by 401
Metadata
- Authors
- Weber, G. F., Zawaideh, S., Hikita, S., Kumar, V. A., Cantor, H., & Ashkar, S.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-10-01
- Volume
- 72
- Issue
- 4
- Pages
- 752-761
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2137354930
- Cited by
- 270
- References
- 36
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.